PhenomeX Alpha and Beta Analysis
| CELLDelisted Stock | 0.60 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PhenomeX. It also helps investors analyze the systematic and unsystematic risks associated with investing in PhenomeX over a specified time horizon. Remember, high PhenomeX's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PhenomeX's market risk premium analysis include:
Beta (1.21) | Alpha (0.79) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PhenomeX |
PhenomeX Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PhenomeX market risk premium is the additional return an investor will receive from holding PhenomeX long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PhenomeX. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PhenomeX's performance over market.| α | -0.79 | β | -1.21 |
PhenomeX Fundamentals Vs Peers
Comparing PhenomeX's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PhenomeX's direct or indirect competition across all of the common fundamentals between PhenomeX and the related equities. This way, we can detect undervalued stocks with similar characteristics as PhenomeX or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PhenomeX's fundamental indicators could also be used in its relative valuation, which is a method of valuing PhenomeX by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PhenomeX to competition |
| Fundamentals | PhenomeX | Peer Average |
| Price To Earning | 22.59 X | 28.72 X |
| Revenue | 78.59 M | 9.43 B |
| EBITDA | (97.03 M) | 3.9 B |
| Net Income | (98.04 M) | 570.98 M |
| Cash And Equivalents | 30.05 M | 2.7 B |
| Cash Per Share | 0.43 X | 5.01 X |
| Total Debt | 4.97 M | 5.32 B |
PhenomeX Opportunities
PhenomeX Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | PhenomeX to Participate in Antibody Engineering Therapeutics Europe 2023 | 06/05/2023 |
About PhenomeX Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PhenomeX or other delisted stocks. Alpha measures the amount that position in PhenomeX has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
PhenomeX Upcoming Company Events
As portrayed in its financial statements, the presentation of PhenomeX's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PhenomeX's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PhenomeX's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PhenomeX. Please utilize our Beneish M Score to check the likelihood of PhenomeX's management manipulating its earnings.
| 14th of November 2023 Upcoming Quarterly Report | View | |
| 22nd of February 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with PhenomeX
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in PhenomeX Stock
If you are still planning to invest in PhenomeX check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhenomeX's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |